Chemotherapy for advanced pancreatic cancer: It may no longer be ignored
Open Access
- 1 January 1999
- journal article
- case report
- Published by Elsevier in Annals of Oncology
- Vol. 10 (1) , 105-110
- https://doi.org/10.1023/a:1008205515591
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- Chemotherapy for pancreatic carcinomaCancer, 1996
- No standard treatment is available for advanced pancreatic cancerEuropean Journal Of Cancer, 1995
- Pancreatic carcinomaAnnals of Oncology, 1995
- Should further studies of chemotherapy be carried out in pancreatic cancer?European Journal Of Cancer, 1993
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. The Gastrointestinal Tumor Study Group.Journal of Clinical Oncology, 1986
- Chemotherapy for advanced pancreatic cancer.A comparison of 5-fluorouracil, adriamycin, and mitomycin (fam) with 5-fluorouracil, streptozotocin, and mitomycin (fsm)Cancer, 1986
- Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group studyCancer, 1983
- Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomised, multicentre trial.BMJ, 1980